Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 Jan;33(1):51–59. doi: 10.1038/bjc.1976.6

Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata.

G A Currie, S A Eccles
PMCID: PMC2024922  PMID: 766806

Abstract

With progressive growth of syngeneic sarcomata in rats there was a rise in serum levels of lysozyme which correlated with their immunogenicity and their macrophage content. By an examination of lymph/blood differences in normal and in tumour bearing rats and of the production of lysozyme by cells obtained from the tumours and maintained in vitro, it is apparent that the macrophages resident in a tumour mass make a massive contribution to the elevation in serum lysozyme concentrations. Tumour cells did not release detectable lysozyme activity. Tumour amputation led to a rapid fall in lysozyme levels. Irradiation of the host rats abolished the lysozyme response and the subsequent development of metastases in these rats was associated with a rise in serum lysozyme. The serum concentration of this enzyme reflects the macrophage content of a tumour mass and the draining lymph nodes. We conclude that under well defined conditions serum lysozyme activity may be a useful marker of macrophage mediated host responses to a tumour.

Full text

PDF
51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CAPPUCCINO J. G., WINSTON S., PERRI G. C. MURAMIDASE ACTIVITY OF KIDNEY AND SPLEEN IN SWISS MICE CHALLENGED WITH B.C.G., ZYMOSAN AND BACTERIAL ENDOTOXINS. Proc Soc Exp Biol Med. 1964 Aug-Sep;116:869–872. doi: 10.3181/00379727-116-29393. [DOI] [PubMed] [Google Scholar]
  2. Eccles S. A., Alexander P. Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature. 1974 Aug 23;250(5468):667–669. doi: 10.1038/250667a0. [DOI] [PubMed] [Google Scholar]
  3. Evans R. Macrophages in syngeneic animal tumours. Transplantation. 1972 Oct;14(4):468–473. doi: 10.1097/00007890-197210000-00011. [DOI] [PubMed] [Google Scholar]
  4. Gordon S., Todd J., Cohn Z. A. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med. 1974 May 1;139(5):1228–1248. doi: 10.1084/jem.139.5.1228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. LITWACK G. Photometric determination of lysozyme activity. Proc Soc Exp Biol Med. 1955 Jul;89(3):401–403. doi: 10.3181/00379727-89-21824. [DOI] [PubMed] [Google Scholar]
  6. McClelland D. B., van Furth R. In vitro synthesis of lysozyme by human and mouse tissues and leucocytes. Immunology. 1975 Jun;28(6):1099–1114. [PMC free article] [PubMed] [Google Scholar]
  7. Osserman E. F., Lawlor D. P. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med. 1966 Nov 1;124(5):921–952. doi: 10.1084/jem.124.5.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. PERRI G. C., CAPPUCCINO J. G., FAULK M., MELLORS J., STOCK C. C. Variations of the content of lysozyme in normal rats and rats bearing Jensen sarcoma following surgery. Cancer Res. 1963 Mar;23:431–435. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES